A Study to Evaluate the Effectiveness and Safety of Infliximab in Chinese Patients With Active Ulcerative Colitis
Clinical trial NCT01551290 · COMPLETED
Trial details
- NCT number
- NCT01551290
- Sponsor
- Xian-Janssen Pharmaceutical Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2014-03-01
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.